Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial symbols : Arvl save search
DOJ Senior Trial Counsel Amy Kossak Joins Ropes & Gray's Government Enforcement Team
Published: 2024-04-09 (Crawled : 20:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
trial
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published: 2024-02-04 (Crawled : 00:00) - globenewswire.com
PLRX | $12.23 -4.9% -5.15% 360K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -5.78%
liver positive fibrosis bexotegrast trial therapeutics
FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Published: 2023-10-11 (Crawled : 17:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 6.48%
H: 4.35%
C: -5.22%
fda vaccine care trial
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.24%
H: 0.0%
C: 0.0%
PLRX | $12.23 -4.9% -5.15% 360K
|
Health Technology
|
| O: 7.89%
H: 11.25%
C: 5.98%
liver positive fibrosis bexotegrast trial therapeutics
Treatment of Severe Heart Failure - AI: FineHeart Strengthens Its Management Team in the Run up to the ICOMS FLOWMAKER® First-In-Human Trials
Published: 2022-10-13 (Crawled : 14:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -0.35%
H: 0.0%
C: 0.0%
flowmaker treatment trials management heart
Enel X and Arrival Partner to Launch Bus Trials in Italy
Published: 2022-06-17 (Crawled : 09:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -4.0%
H: 0.0%
C: 0.0%
trials trial
ASCO Preview: Immutep, InxMed and Faron Release New Clinical Findings
Published: 2022-05-31 (Crawled : 14:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: 0.0%
asco
SEC Regional Trial Counsel Amy Jane Longo Joins Ropes & Gray's Litigation & Enforcement Team as Partner in Los Angeles
Published: 2022-03-21 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -2.14%
H: 0.0%
C: 0.0%
trial
COVID-19 Changed the Biopharma Industry - and There's No Going Back
Published: 2022-03-09 (Crawled : 06:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 5.73%
H: 0.0%
C: 0.0%
covid-19 biopharma covid
Industrial Automation Market size worth $ 350 Billion, Globally, by 2028 at 7.8% CAGR: Verified Market Research®
Published: 2022-02-16 (Crawled : 17:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.75%
H: 5.85%
C: 5.09%
research trial market
Arrival begins proving ground trials of its electric Bus
Published: 2021-12-28 (Crawled : 10:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.51%
H: 6.0%
C: 1.79%
als trials trial
Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)
Published: 2021-09-28 (Crawled : 14:15) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -0.59%
H: 0.3%
C: -2.44%
stroke phase 2 neurological life science
CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up
Published: 2021-09-21 (Crawled : 08:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -0.36%
H: 2.24%
C: 0.4%
trial
Global Bispecific Antibody Therapeutics Market Forecast Clinical Trials Drug Approval Insight 2028
Published: 2021-08-02 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.15%
H: 1.54%
C: -1.38%
clinical trials antibody drug trial approval
Medable Launches Digital Certification Program to Accelerate Adoption of Decentralized Clinical Trials
Published: 2021-06-24 (Crawled : 16:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.11%
H: 4.43%
C: 1.12%
clinical trials trial
Behind the Wheel: An electrifying partnership – CNH Industrial and Nikola Corporation
Published: 2021-06-17 (Crawled : 11:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -2.32%
H: 0.89%
C: -2.7%
CNHI | News | $12.4 0.32% 1.13% 6.1M
|
Producer Manufacturing
|
| O: 0.06%
H: 0.41%
C: -2.44%
NKLA | $0.6601 2.6% 2.53% 45M
|
Consumer Durables
|
| O: 2.03%
H: 6.78%
C: 5.78%
partnership trial
Eagle Alpha Announces 3 Key Drivers To Industry Excellence - Trial Dataset Delivery, Data Platform Technology and Stronger Partnerships
Published: 2021-05-25 (Crawled : 12:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.7%
H: 3.3%
C: 2.83%
partnership technology liver trial
Gamma Delta T Cell Cancer Immunotherapy Clinical Research Trials Pipeline Outlook 2026
Published: 2021-04-23 (Crawled : 14:15) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 3.38%
H: 10.07%
C: 9.93%
immunotherapy therapy cancer research trial t-cell
Global C5 Complement Inhibitors Drug Market Sales Clinical Trials Opportunity USD 15 Billion 2026
Published: 2021-04-18 (Crawled : 16:20) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
trial sales clinical trials drug
Global C5 Complement Inhibitor Soliris Ultomiris Market Clinical Trial Research Outlook 2026
Published: 2021-04-18 (Crawled : 16:20) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
trial research
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.